ReviewCurrent gastroenterology reports2013
Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance.
Review in Current gastroenterology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 18 citations in OpenAlex.
- A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett's esophagus: literature and review.Surgical case reports · 2018Article
- Screening and Preventive Strategies in Esophagogastric Cancer.Surgical oncology clinics of North America · 2017Review
- Gastrointestinal symptoms and disorders in patients with eating disorders.Clinical journal of gastroenterology · 2015Review
- State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Journal of gastrointestinal oncology · 2015Review
- Gastrointestinal morbidity in obesity.Annals of the New York Academy of Sciences · 2014Review
- Recent advances in molecular imaging of premalignant gastrointestinal lesions and future application for early detection of barrett esophagus.Clinical endoscopy · 2014Review
- Barrett esophagus: history, definition and etiopathogeny.Journal of medicine and life · 2014Review
- Esophageal cancer: Recent advances in screening, targeted therapy, and management.Journal of carcinogenesis · 2014Review
- Application of confocal laser endomicroscopy in the diagnosis and management of Barrett's esophagus.Annals of gastroenterology · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Barrett's esophagus (BE) is the only established precursor lesion in the development of esophageal adenocarcinoma (EAC) and it increases the risk of cancer by 11-fold. It is regarded as a complication of gastroesophageal reflux disease. There is an ever-increasing body of knowledge on the pathogenesis, diagnosis, treatment, and surveillance of BE and its associated dysplasia. In this review, we summarize the latest advances in BE research and clinical practice in the past 2 years. It is critical to understand the molecular underpinnings of this disorder to comprehend the clinical outcomes of the disease. For clinical gastroenterologists, there is also continuous growth of endoscopic approaches which is daunting, and further improvements in the detection and treatment of BE and early EAC are anticipated. In the future, we may see the increased role of biomarkers, both molecular and imaging, in both diagnostic and therapeutic strategies for BE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.